Implementation and evaluation of SDM in AKD

Implementation and evaluation of shared decision-making, supported by outcome measures, for treatment modality decisions in advanced kidney disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21318

Enrollment

630

Registered

2020-02-12

Start date

2019-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD-KDIGO G4-G5A1-3

Interventions

Healthcare professionals, guiding patients facing the decision for a treatment modality in advanced kidney disease, will be introduced to a patient decision aid including (personalised) care outcomes,

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with CKD-KDIGO G4-G5A1-3 kidney failure; 2) Having to make treatment modality decisions; 3) Age = 18 years; 4) Understand the Dutch language in speech and writing; 5) Able to provide informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with dementia; 2) Patients that have already made treatment modality decisions and are being prepared for this treatment or are receiving this treatment.

Design outcomes

Primary

Measure	Time frame
Patients' perceived level of involvement in the decision-making process (using the SDM-Q-9).	—

Secondary

Measure	Time frame
Patients' involvement in the decision-making process from the observers' viewpoint (using the OPTION-5).	—

Contacts

Public ContactMariska Hackert

Santeon

m.hackert@santeon.nl030-3073910

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)